Quality of life, chronic pain, insomnia, and jaw malfunction in patients after alloplastic temporomandibular joint replacement: a questionnaire-based pilot study.

Studies of patients undergoing alloplastic total temporomandibular joint replacement seldom report on quality of life (QoL) and sleep. The aim of this pilot study was to assess these factors in such a patient cohort using validated psychometric questionnaires. Data were collected via online surveys comprising the following six questionnaires: Short Form-12 Health Survey (SF-12), Patient Health Questionnaire-15, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30, Insomnia Severity Index, Graded Chronic Pain Scale, and Jaw Disability List. Pain intensity, limitation in nutrition, and treatment satisfaction were assessed using numerical rating scales. Mouth opening was measured at follow-up. The SF-12 Physical Composite Score was markedly lower than that of the age-matched general population, whereas the Mental Composite Score did not differ significantly. Participants indicated a low somatization level and low level of disability due to pain, but reduced QoL. Clinically relevant insomnia was reported by 36% of participants. In conclusion, the results of this pilot study indicate that QoL and sleep in patients with a total temporomandibular joint replacement differ from those in the general population, indicating the need for a comprehensive outcome assessment utilizing validated psychometric tools in accordance with the current biopsychosocial model of chronic disorders.

[Validation of the German-language version of the Injustice Experience Questionnaire (IEQ) in five outpatient clinics]. / Validierung der deutschen Übersetzung des Injustice Experience Questionnaire (IEQ) in 5 ambulanten Schmerzbehandlungseinrichtungen.

INTRODUCTION: Occupational and social rehabilitation can be influenced by perceived injustice that results from pain. Currently, the Injustice Experience Questionnaire (IEQ), the tool most commonly used to assess perceived injustice, is not available in German. The aim of this study was the validation of the German-language version of the IEQ. MATERIALS AND METHODS: The validation of the IEQ was carried out via a web-based survey. For this purpose, participants completed the IEQ and construct-related scales analogous to the original study Tampa Scale of Kinesiophobia (TSK), Depression scale of the Depression Anxiety and Stress Scales (D-DASS), Pain Disability Index (PDI), and McGill Pain Questionnaire (MPQ). In addition, the participants completed questions on their socioeconomic status and on the cause of their pain, taken from the German Pain Questionnaire. RESULTS: Of 223 respondents, 134 (60.1%) returned a completed questionnaire and were included in the study. In all, 26.1% of participants reported suffering from pain resulting from accidents. None of the reviewed one- to three-factor solutions for the IEQ's structure achieved a good model fit. The best results were found for a two-factor solution, whereby the exploratory factor analysis revealed almost all items loaded highly on both factors and the confirmatory factor analysis showed high correlations between the factors. These findings are consistent with previous studies. The IEQ correlated highly and significantly with the other psychological instruments. There were no floor or ceiling effects. Cronbach's α for the German IEQ version was 0.93 and thus attests a high level of internal consistency. CONCLUSION: The analyses attest the excellent psychometric properties of the German translation of the IEQ and so the German-language version of the IEQ can be used as a validated questionnaire to screen for perceived injustice.

[German transcultural translation of the Injustice Experience Questionnaire]. / Deutsche transkulturelle Übersetzung des Injustice Experience Questionnaire.

BACKGROUND: Occupational and social rehabilitation is influenced by perceived injustice as a result of injury. To assess perceived injustice, the Injustice Experience Questionnaire (IEQ) has been developed and is available in English. The aim of this study was to translate and culturally adapt the English version of the IEQ into German. MATERIALS AND METHODS: The IEQ was translated into German according to the criteria for the transcultural adaptation of self-assessment tools. The translation was examined in a sample of 19 pain patients as to whether the translated items were comprehensible, unacceptable or offensive, and what their meaning and the reason for the chosen response were. Data were assessed using nonparametric statistical methods. RESULTS: The German translation of the IEQ showed a high degree of comprehensibility. The items' meanings and participants' selected answer options were rated as highly plausible by two raters and the wording of the items was assessed as being neither unacceptable nor offensive by participants. Because of the slightly increased values with regard to Item 3, whose meaning was unrecognized by the raters, the term "Unachtsamkeit" was replaced by "Unaufmerksamkeit." CONCLUSION: The study attests to the cultural and linguistic intelligibility and precision of the German translation of the IEQ. In a follow-up study, the translation should be validated in a larger sample of pain patients.

[Distinctive features of orofacial pain perception]. / Besonderheiten der orofazialen Schmerzempfindung.

BACKGROUND: In the widely used German pain questionnaire, qualitative pain characteristics are assessed by the Schmerzbeschreibungsliste (SBL). In clinical practice these adjectives insufficiently cover the spectrum of orofacial pain perceptions (OFP) and have not been proven by data. The aim of this study was the analysis of a questionnaire focussing on OFP (ZZM-FB) in which nine additional pain descriptors were amended to the SBL (SBL-OF). OBJECTIVES: The objectives of this work were to (1) compare selection frequencies between the items of the SBL and the SBL-OF and (2) test the null hypothesis that the SBL and SBL-OF item selection is not influenced by gender, age, pain features (intensity, duration, time pattern, distribution), hospital anxiety and depression scale (HADS) and diagnosis. MATERIAL AND METHODS: A total of 224 patients consecutively referred to the interdisciplinary OFP unit between 2010 and 2012 completed a ZZM-FB. The corresponding diagnosis was obtained from the clinical reports. In all, 209 OFP-Q were anonymized and data retrospectively analysed at a significance level of p ≤ 0.01. RESULTS: The descending rank order of the 12 most frequently selected items was as follow: pressing (SBL), dull (SBL), pulling (SBL), stinging (SBL), dreadful (SBL), miserable (SBL), exhausting (SBL-OF), grueling (SBL-OF), agonizing (SBL-OF), atrocious (SBL), horrible (SBL), pulsating (SBL). The null hypothesis was rejected for all parameters except for age. The selection frequency was significantly influenced by gender, pain intensity, duration and distribution, time pattern, HADS values and diagnosis. CONCLUSIONS: In this cohort, some ADD descriptors were selected more frequently than some SBL items, indicating that the SBL does not adequately capture the characteristics of OFP. These results will be considered in the construction of a revised ZZM-FB, which is currently in development.

A stochastic empirical model for regional heavy-metal balances in agroecosystems.

Mass flux balancing provides essential information for preventive strategies against heavy-metal accumulation in agricultural soils that may result from atmospheric deposition and application of fertilizers and pesticides. In this paper we present the empirical stochastic balance model, PROTERRA-S, that estimates heavy-metal and phosphorus accumulation in agricultural soils on the regional level. The basic units of these balances are land use systems defined by livestock production and cultivated crops. The model is designed to use available databases, such as regional agricultural statistics and soil information systems. In a case study, we assessed the phosphorus, cadmium, and zinc balances for the Sundgau region, Switzerland. The regional P requirements of crops were mainly supplied by animal manure (56%) and commercial fertilizers (40%). Net cadmium fluxes of the land use systems ranged from 1.0 g ha(-1) yr(-1) (dairy and mixed farm types) to 17.8 g ha(-1) yr(-1) (animal husbandry systems), whereas the regional net cadmium flux was only 1.4 g ha(-1) yr(-1). The regional net zinc flux was 605 g ha(-1) yr(-1). The smallest net zinc flux of 101 g ha(-1) yr(-1) was found for an arable farm type, whereas for animal husbandry systems fluxes up to 39.8 kg ha(-1) yr(-1) were estimated. Comparison of model results with reported metal balances of experimental farms shows that identification of agricultural land with high risks of heavy-metal accumulation benefits from stratification of heavy-metal balances according to land use systems while accounting for their P fertilization plans. Consequently, the model may support sustainable management of heavy-metal cycles in agricultural soils.

Femtosecond Dynamics of Dioxygen - Picket-Fence Cobalt Porphyrins: Ultrafast Release of O(2) and the Nature of Dative Bonding.

The ultrafast release of O(2) from the O(2) adduct of picket-fence cobalt porphyrin (see picture) has been probed in real time, and has a total reaction time of 2 ps, without subsequent recombination over several nanoseconds. The dynamics of this ultrafast release of O(2) shows that relaxation within the porphyrin system (200 fs) precedes porphyrin-to-metal electron transfer, but the latter occurs at an enhanced rate (500 fs as opposed to the more usual 1 - 2 ps) because of the dative bonding of cobalt and O(2), which gives the adduct ground state significant Co(III)-O(2)(-) character.

[Occurrence of bovine ehrlichiosis in the canton Obwalden]. / Auftreten von boviner Ehrlichiose im Kanton Obwalden.

Due the examination of six Brown Swiss cows the "Schinberg-fever" a clinical picture known for years in central Switzerland could be identified as bovine ehrlichiosis. Clinical signs were observed 23 to 116 days after the animals were turned out on pasture. Main symptoms were fever and reduced milk yield. All animals were infested with ticks and showed a severe leucopenia. In buffy coat preparations Ehrlichia phagocytophila could be identified in neutrophils and eosinophils, rarely in monocytes. All six cows could be successfully treated with oxytetracycline.

Mapping heavy metals in polluted soil by disjunctive kriging.

The soil of some 50 km(2) around the town of Weinfelden in north-east Switzerland has been sampled and analysed to estimate and map the concentrations of heavy metals before an incinerator for the canton's waste is built. Given that the estimates are subject to error, the probabilities that true values exceed the maximum tolerable concentrations of the Swiss federal guide have also been estimated by disjunctive kriging. These may now be used by the local planners for making decisions. Of the metals examined, lead exceeded the guide value at several sampling points, and a moderate probability of excess of lead is fairly widespread. Copper exceeded the guide value in vineyards and orchards, but also in a few places elsewhere, and the estimated probabilities of excess were not negligible. The other two metals of concern, cadmium (with one exception) and zinc, had concentrations much less than the guide values. The patterns of distribution of the four metals were similar, the product-moment correlations among them are substantial, except in the vineyards and orchards, and it seems likely that they had common sources.

Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials.

PURPOSE: Pilocarpine hydrochloride administered in either a fixed-dose or in a dose-titration protocol three times a day for 12 weeks was evaluated for its ability to relieve symptoms of postradiation xerostomia and to improve saliva production. The studies were randomized, double-blind, placebo-controlled, multicenter clinical trials. A total of 369 patients who had received at least 40 Gy of radiation to the head and neck with clinically significant xerostomia were enrolled in the two studies. In the dose-titration study, 162 patients were enrolled and they received a thrice daily regimen of 2.5 mg tablets for first 4 weeks, 5.0 mg tablets for the second 4 weeks, and 10.0 mg tablets for last 4 weeks of a 12-week study. Patients in the titration study were allowed to down titrate following at least one dose escalation to alleviate bothersome side effects, if any. In the fixed dose study, 207 patients received either placebo, 5.0 mg, or 10.0 mg tablets t.i.d. for 12 weeks. METHODS AND MATERIALS: Patients were evaluated for symptomatic relief by responding to questionnaires using visual analog scales and categorical questions; and, for saliva production by sialometry. Questionnaires measured relief of intraoral dryness, improvement in overall condition (global response), oral discomfort, difficulty in speaking, chewing and swallowing, denture wearing, and usage of artificial saliva. Evaluations were conducted at baseline, and weeks 4, 8, and 12. RESULTS: There were statistically significant improvements in salivary flow in pilocarpine treatment groups vs. placebo. There was a significant improvement in the overall "global" condition of xerostomia associated with the use of pilocarpine in both studies. In the fixed-dose study, there were significant improvements in oral dryness, mouth comfort, ability to speak, and reduction in the use of oral comfort agents. The dose-titration study showed improvements in dryness that approached significance (p = 0.057) and a decreased use of oral comfort agents (p = 0.045). All pilocarpine dosages (2.5, 5.0, and 10.0 mg three times a day) were judged to be safe. Adverse experiences were those expected for a cholinergic agonist, with the most common being mild to moderate sweating. The incidence of these events increased by dose. CONCLUSION: It is concluded that in these studies pilocarpine produced clinically significant benefits with acceptable side effects and risks for the treatment of symptomatic postradiation xerostomia. The incidence of most adverse events increased with dose. Best results may require continuous treatment for more than 8 weeks with doses greater than 2.5 mg three times a day. A 5.0 mg thrice daily regimen produced the best clinical results when both efficacy and side effects were taken into consideration. There may be some patients who would experience some additional benefit by increasing the dose to 10 mg thrice daily.

A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients.

PURPOSE: To determine the efficacy and safety of pilocarpine hydrochloride for symptomatic relief of postradiation xerostomia symptoms and for saliva production in patients with head and neck cancer. PATIENTS AND METHODS: One hundred sixty-two head and neck cancer patients who had received at least 40 Gy of radiation (117 patients had received > 60 Gy) with clinically significant xerostomia were enrolled onto a randomized, double-blind, placebo-controlled, multi-center clinical investigation. Patients received 2.5-mg tablets for the first 4 weeks, 5.0-mg tablets for the second 4 weeks, and 10.0-mg tablets for the last 4 weeks of the 12-week study. Patients were allowed to titrate pilocarpine or placebo for improvement in symptoms or to reduce side effects. Patients were evaluated for symptomatic relief by questionnaires and visual analog scales (VAS), and for saliva production by sialometry. RESULTS: Pilocarpine produced a significant improvement (P = .035) in overall global assessments compared with placebo. There was a statistically significant (P = .020) decreased use of oral comfort agents such as artificial saliva, hard candy, and water. Values for symptomatic improvement in dryness approached significance (P = .057). There were statistically significant postdose improvements in whole and parotid salivary flow in pilocarpine treatment groups versus placebo. All pilocarpine dosages tested were judged to be safe. Adverse experiences were primarily sweating, rhinitis, headache, nausea, and urinary frequency, with the most common side effect being mild to moderate sweating. There were no serious drug-related adverse experiences in any of the pilocarpine treatment groups. CONCLUSION: It is concluded that pilocarpine produces clinically significant benefits for the symptomatic treatment of postradiation xerostomia. Best results were obtained with continuous treatment for 8 to 12 weeks with doses greater than 2.5 mg three times per day.

Hydralazine dose-response curve analysis.

A multicenter, parallel, double-blind, 181-patient study compared the safety and antihypertensive efficacy of immediate-release (IR) and extended-release (ER) hydralazine. After 2 to 4 weeks on diuretic, patients were maintained on diuretic and randomized to a hydralazine treatment regimen: IR thrice daily, ER twice daily, or ER once daily. Daily doses of hydralazine were 75, 150, or 300 mg. Although designed as a titration study, important dose-response data were available for analysis with nonlinear mixed effect modeling (NONMEM). Sitting diastolic blood pressure (BP) was selected as the response variable. Several factors were tested for importance, including body weight, time (week) effects, concomitant beta-blocker (BB) therapy, acetylator class, and treatment regimen. All factors were important (p less than 0.05) except treatment regimen (p greater than 0.30). The maximum antihypertensive response (Emax) to hydralazine was 9.4 mm Hg. The daily dose that elicited 50% of the maximum response (D50) was 0.87 mg/kg for slow acetylators and 1.68 mg/kg for fast acetylators. BP fell 0.52 mm Hg per week independent of other effects, and concomitant BB therapy induced a drop of 6.6 mm Hg in addition to hydralazine, diuretic and week effects. NONMEM's use assisted in evaluations and provided information not obtainable through traditional means.